Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 38,802 | 41,482 | 44,086 | 12,184 | 15,354 |
| Other current assets | 114 | 205 | 241 | 490 | 134 |
| TOTAL | $38,916 | $41,687 | $44,327 | $12,674 | $15,488 |
| Non-Current Assets | |||||
| PPE Net | 28 | 31 | 34 | 34 | 36 |
| Other Non-Current Assets | 630 | 679 | 754 | 553 | 608 |
| TOTAL | $658 | $710 | $788 | $587 | $644 |
| Total Assets | $39,574 | $42,397 | $45,115 | $13,261 | $16,132 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 364 | 647 | 714 | 651 | 795 |
| Accrued Expenses | 1,140 | 657 | 642 | 482 | 593 |
| TOTAL | $1,504 | $1,304 | $1,356 | $1,133 | $1,388 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $1 | $1 | $3 |
| Total Liabilities | $1,504 | $1,304 | $1,357 | $1,134 | $1,391 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42 | 42 | 42 | 14 | 14 |
| Common Shares | 9 | 9 | 63 | 21 | 3 |
| Retained earnings | -96,067 | -92,899 | -90,085 | -87,366 | -84,622 |
| TOTAL | $38,070 | $41,093 | $43,758 | $12,127 | $14,741 |
| Total Liabilities And Equity | $39,574 | $42,397 | $45,115 | $13,261 | $16,132 |